Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- Global burden of disease
- Causes of resistant hypertension
- Consensus guidelines
- Guidelines and camels
- Hypertension control: what can it achieve?
- Hyaline degeneration
- Fibrinoid necrosis
- Cerebellar hemorrhage
- The vascular centrencephalon
- Active detection & treatment of hypertension
- Stimulated renin testing
- Visitors from other clinics
- Causes of hypertension in a referral population
- Buxton national historic site & museum
- The Elgin settlement
- Bilateral adrenocortical hyperplasia
- Hypertension is different in African-Americans
- Low-renin hypertension in African-Americans
- Causes of low-renin hypertension
- Blacks excrete a water load less well
- Different response to therapy
- Central role of renin-angiotensin-aldosterone
- Physiologically individualized therapy
- Primary aldosteronism
- Liddle’s variants
- ENaC R563Q variant
- R563Q variant in Cape Town and Johannesburg
- Recent advances
- Liddle’s variant? So what?
- More than one cause of hypertension
- Physiological phenotyping: a study in Africa
- Results of a trial in Africa
- Genetic variants and salt & water retention
- Conclusion
- Final remarks
Topics Covered
- Causes of resistant hypertension
- Physiologically individualized therapy
- Special issues for black patients (Low renin hypertension)
- Multiple causes of hypertension
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Spence, J.D. (2017, December 31). Controlling resistant hypertension [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/BHDC5854.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. J. David Spence has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Stroke Prevention
Transcript
Please wait while the transcript is being prepared...
0:00
I'm David Spence. I'm a Professor of Neurology and
Clinical Pharmacology at Western University in London,
Canada, and this talk is about Controlling Resistant Hypertension.
0:12
The topics that I'll get into are the causes of resistant hypertension,
and approach to individualized therapy for
resistant hypertension based on the patient's physiology.
Some special issues for black patients who tend to have low plasma renin levels,
and a brief discussion of patients with multiple causes of hypertension.
0:34
So, in the Global burden of disease, April 9 of
2012, hypertension reached the top
of the list as the cause of death and disability in the world.
It's a huge problem in Africa.
In Nairobi, hypertension clinics,
75 percent of the treated hypertensives have poor blood pressure control.
0:55
The causes of resistant hypertension include three broad categories or maybe more.
First is non-compliance.
So, about half the patients will admit that they're not taking pills.
Compliance is better with drugs that have less adverse effects.
One of the problems obviously is the cost of medication,
so keeping medication inexpensive is helpful with
possible, particularly in impoverished areas.
Second broad category is things that patients
put in their mouth that aggravates their hypertension,
which includes salt, licorice, non-steroidals,
too much alcohol, birth control pills, and decongestants.
Patients who salt their food before tasting, are on average,
consuming about 10 grams a day of salt,
and the body only needs about half a gram.
So, desirable salt intake for patients with
hypertension is around two to three grams a day, which means,
not only no added salt but also avoidance of
salty foods such as pickles and canned soups and cured meats.
The only non-steroidal anti-inflammatory agent
that does not raise blood pressure is Sulindac.
That was a paper in Lancet 1986,
David Wong was the first author and I was the second.
And too much ethanol can be
a significant problem that the patient may not tell you about, so you need to ask.
The problem with licorice is that it has a mineralocorticoid
effect so, it can cause high blood pressure with low potassium,
and it can look like primary aldosteronism and also cause a low renin.
However, the aldosterone level will also be low because of the salt and water retention.
Now the third broad category is secondary hypertension
an underlying cause of the hypertension that can be diagnosed.
And the most neglected of these,
bilateral adrenocortical hyperplasia causing primary hyperaldosteronism,
and variants of Liddle syndrome,
and other sodium channel mutations in the renal tubule causing salt and water retention,
and these may be especially important in African-Americans and in Africans.
The fourth category of problem is,
consensus guidelines, that assumes that all patients are the same.
And the fifth broad category is doctors who don't think.